Tace
15 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma (NCT05131698) | Cancer Hospital of Guangxi Medical University | 2021-03-01 |
| Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence (NCT04213118) | First Affiliated Hospital Xi'an Jiaotong University | 2020-04-23 |
| Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1 (NCT02724358) | Eastern Hepatobiliary Surgery Hospital | 2012-12-01 |
| Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma (NCT01415063) | Sun Yat-sen University | 2011-02-01 |
Track Tace automatically
Every clearance here is in the API, with alerts when new ones post.